OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Since then, Musk hasn’t hidden his anger with Altman and OpenAI. He’s currently suing the company over its decision to become ...

WIth one foot out the White House door, the Biden administration issued 2 documents Musk is now using in his battle to break ...

President Trump and Elon Musk aren’t an exclusive item. That point was clear this week when the president welcomed OpenAI ...

In the latest development in the pair’s longtime feud, Elon Musk, a key White House advisor as well as the founder of AI ...

Earlier this week, he unveiled perhaps the most ambitious infrastructure project in history—and all but dedicated it to Sam ...

OpenAI CEO Sam Altman has unveiled a new initiative called Operator. It is the company's first AI agent capable of acting ...

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...

Wednesday on the RealClearPolitics podcast, Andrew Walworth, Tom Bevan, and Carl Cannon discussed President Trump introducing ...

It comes following online spat between Musk and OpenAI CEO Sam Altman over Stargate artificial intelligence infrastructure project ...